Correction to: In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016

Publisher Correction: European Journal of Clinical Microbiology & Infectious Diseases

https://doi.org/10.1007/s10096-019-03517-y

The publisher regrets that the article has been published online on 01 March 2019 with errors in Table 1.

Table 1 MIC and cumulative percent inhibited distributions for imipenem-relebactam and comparators, in relation to the carbapenemase type produced by the 314 K. pneumoniae isolates

In the originally published Table 1, the percentage of Imipenem-relebactam susceptibility was incorrectly written as 8 0, while correct data is 98.0. Also, in Meropenem row, column MIC₅₀ (mg/L), the incorrect data 4 should be 64.

Subsequently, the revised Table 1 with the corrected data is shown below.

The original article has been corrected.